Does coffee consumption alter plasma lipoprotein(a) concentrations? A systematic review

Authors:

Peter Penson | Maria-Corina Serban | Sorin Ursoniu | Maciej Banach | for the Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group

First published: 24 Aug 2017 | https://doi.org/10.1080/10408398.2016.1272045

Abstract:

Coffee consumption alters plasma lipid and cholesterol concentrations, however, its effects on lipoprotein(a) (Lp(a)) have received little study. The aim of this PRISMA compliant systematic review was to examine the role of coffee on serum Lp(a).

This study was prospectively registered (PROSPERO 2015:CRD42015032335). PubMed, Scopus, Web of Science and Cochrane Central were searched from inception until 9th January 2016 to detect trials and epidemiological studies investigating the impact of coffee on serum Lp(a) concentrations in humans.

We identified six relevant publications describing nine experimental trials of various designs. There were a total of 640 participants across all studies and experimental groups. In short-term controlled studies, consumption of coffee, or coffee diterpenes was associated with either a reduction in serum Lp(a) of ≤11 mg/dL (6 trials, 275 participants), or no effect (2 trials, 56 participants). Conversely, one cross-sectional study with 309 participants showed serum Lp(a) was elevated in chronic consumers of boiled coffee who had a median Lp(a) of 13.0 mg/dL (range 0–130) compared with consumers of filtered coffee who had median Lp(a) 7.9 mg/dL (range 0–144).

The effect of coffee on Lp(a) is complex and may follow a biphasic time-course. The type of coffee and the method of preparation appear to be important to determining the effect on Lp(a).

ACKNOWLEDGEMENTS

We are grateful to the following individuals who kindly provided quantitative information on Lp(a) or other additional details which was not reported in their papers. Dr Telma Faraldo Correa provided information on (Correa et al. 2013) and Dr Elisabeth Strandhagen provided information on (Strandhagen and Thelle, 2003).

Additional information

This systematic review has been prepared within Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group (www.lbpmcgroup.umed.pl). The authors declare no competing financial interests.

Declaration of interests

The authors declare no competing financial interests.

Conflict of interest disclosures

None.

Funding

REFERENCES

Bos, S., Yayha, R. and van Lennep, J. E. (2014). Latest developments in the treatment of lipoprotein (a). Curr. Opin. Lipidol. 25(6):452–460.
Bukowska, H., Goracy, I., Chelstowski, K. and Naruszewicz, M. (2006). The assessment of the influence of natural coffee and its modified form on the level of homocysteine, vitamin B6 and folic acid in healthy volunteers. Polski merkuriusz lekarski : Organ Polskiego Towarzystwa Lekarskiego 20(116):176–179.
Cai, L., Ma, D., Zhang, Y., Liu, Z. and Wang, P. (2012). The effect of coffee consumption on serum lipids: a meta-analysis of randomized controlled trials. Eur. J. Clin. Nutr. 66(8):872–877.
Correa, T. A., Rogero, M. M., Mioto, B. M., Tarasoutchi, D., Tuda, V. L., Cesar, L. A. and Torres, E. A. (2013). Paper-filtered coffee increases cholesterol and inflammation biomarkers independent of roasting degree: a clinical trial. Nutrition 29(7–8):977–981.
Doepker, C., Lieberman, H. R., Smith, A. P., Peck, J. D., El-Sohemy, A. and Welsh, B. T. (2016). Caffeine: Friend or Foe? Food Sci. Technol. 7.
Dusseldorp, M., Katan, M. B., Vliet, T., Demacker, P. N. and Stalenhoef, A. F. (1991). Cholesterol-raising factor from boiled coffee does not pass a paper filter. Arteriosclerosis Thrombosis 11(3):586–593.
Gregory, W. L., Game, F. L., Farrer, M., Idle, J. R., Laker, M. F. and James, O. F. W. (1994). Reduced serum lipoprotein(a) levels in patients with primary biliary-cirrhosis. Atherosclerosis 105(1):43–50.
Heckers, H., Gobel, U. and Kleppel, U. (1994). End of the coffee mystery: diterpene alcohols raise serum low-density lipoprotein cholesterol and triglyceride levels. J Intern Med 235(2):192–193.
Higgins, J. P. T., Altman, D. G., Gøtzsche, P. C., Jüni, P., Moher, D., Oxman, A. D., Savović, J., Schulz, K. F., Weeks, L. and Sterne, J. A. C. (2011). The cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343.
Higgins, J. P. T. and Green, S. (2011). Cochrane handbook for systematic reviews of interventions. Cochrane Collaboration.
Jee, S. H., He, J., Appel, L. J., Whelton, P. K., Suh, I. and Klag, M. J. (2001). Coffee consumption and serum lipids: a meta-analysis of randomized controlled clinical trials. Am. J. Epidemiology 153(4):353–362.
Kamstrup, P. R., Tybjaerg-Hansen, A., Steffensen, R. and Nordestgaard, B. G. (2009). Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. JAMA 301(22):2331–2339.
Nave, A. H., Lange, K. S., Leonards, C. O., Siegerink, B., Doehner, W., Landmesser, U., Steinhagen-Thiessen, E., Endres, M. and Ebinger, M. (2015). Lipoprotein (a) as a risk factor for ischemic stroke: A meta-analysis. Atherosclerosis 242(2):496–503.
Puckey, L. and Knight, B. (1999). Dietary and genetic interactions in the regulation of plasma lipoprotein(a). Curr. Opin. Lipidology 10(1):35–40.
Strandhagen, E. and Thelle, D. S. (2003). Filtered coffee raises serum cholesterol: Results from a controlled study. Eur. J. Clin. Nutr. 57(9):1164–1168.
Urgert, R. and Katan, M. B. (1997). The cholesterol-raising factor from coffee beans. Annu. Rev. Nutr. 17:305–324.
Urgert, R., Vanderweg, G., Kosmeijerschuil, T. G., Vandebovenkamp, P., Hovenier, R. and Katan, M. B. (1995). Levels of the cholesterol-elevating diterpenes cafestol and kahweol in various coffee brews. J. Agric. Food Chem. 43(8):2167–2172.
Urgert, R., Weusten-van der Wouw, M. P., Hovenier, R., Lund-Larsen, P. G. and Katan, M. B. (1996). Chronic consumers of boiled coffee have elevated serum levels of lipoprotein(a). J. Intern. Med. 240(6):367–371
Urgert, R., Weusten-van der Wouw, M. P., Hovenier, R., Meyboom, S., Beynen, A. C. and Katan, M. B. (1997). Diterpenes from coffee beans decrease serum levels of lipoprotein(a) in humans: results from four randomised controlled trials. Eur. J. Clin. Nutr. 51(7):431–436.
Vanrooij, J., Vanderstegen, G. H. D., Schoemaker, R. C., Kroon, C., Burggraaf, J., Hollaar, L., Vroon, T., Smelt, A. H. M. and Cohen, A. F. (1995). A placebo-controlled parallel study of the effect of 2 types of coffee oil on serum-lipids and transaminases – identification of chemical-substances involved in the cholesterol-raising effect of coffee. Am. J. Clin. Nutr. 61(6):1277–1283.
Vanwersch, J. W. J. (1994). The behavior of lipoprotein(a) in patients with various diseases. Scand. J. Clin. Lab. Investigation 54(7):559–562.
Weustenvanderwouw, M., Katan, M. B., Viani, R., Huggett, A. C., Liardon, R., Lundlarsen, P. G., Thelle, D. S., Ahola, I., Aro, A., Meyboom, S. and Beynen, A. C. (1994). Identity of the cholesterol-raising factor from boiled coffee and its effects on liver-function enzymes. J. Lipid Res. 35(4):721–733.
Yukawa, G. S., Mune, M., Otani, H., Tone, Y., Liang, X. M., Iwahashi, H. and Sakamoto, W. (2004). Effects of coffee consumption on oxidative susceptibility of low-density lipoproteins and serum lipid levels in humans. Biochem. (Mosc) 69(1):70–74.